Related Articles
Survivin selective inhibitor YM155 promotes cisplatin‑induced apoptosis in embryonal rhabdomyosarcoma
MicroRNA‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting Stanniocalcin 1
Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS
YM155 exerts a growth inhibitory effect on human osteosarcoma in vitro and in vivo
Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma